Subject Area物理化学
Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
Lehmann, Rainer1,2; Franken, Holger3; Dammeier, Sascha4; Rosenbaum, Lars3; Kantartzis, Konstantinos1,2; Peter, Andreas1,2; Zell, Andreas3; Adam, Patrick5; Li, Jia6; Xu, Guowang6; Koenigsrainer, Alfred7; Machann, Juergen8; Schick, Fritz8; de Angelis, Martin Hrabe9; Schwab, Matthias10,11; Staiger, Harald1,2; Schleicher, Erwin1,2; Gastaldelli, Amalia12; Fritsche, Andreas1,2; Haering, Hans-Ulrich1,2; Stefan, Norbert1,2; Norbert Stefan
Source PublicationDIABETES CARE
Indexed BySCI
Cooperation Status
Funding Project1808
Contribution Rank待补充
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
Funding Organization6,9 ; 6,9 ; 6,9 ; 6,9
WOS SubjectEndocrinology & Metabolism
WOS Research AreaEndocrinology & Metabolism
AbstractOBJECTIVENonalcoholic fatty liver (NAFL) is thought to contribute to insulin resistance and its metabolic complications. However, some individuals with NAFL remain insulin sensitive. Mechanisms involved in the susceptibility to develop insulin resistance in humans with NAFL are largely unknown. We investigated circulating markers and mechanisms of a metabolically benign and malignant NAFL by applying a metabolomic approach.RESEARCH DESIGN AND METHODSA total of 265 metabolites were analyzed before and after a 9-month lifestyle intervention in plasma from 20 insulin-sensitive and 20 insulin-resistant subjects with NAFL. The relevant plasma metabolites were then tested for relationships with insulin sensitivity in 17 subjects without NAFL and in plasma from 29 subjects with liver tissue samples.RESULTSThe best separation of the insulin-sensitive from the insulin-resistant NAFL group was achieved by a metabolite pattern including the branched-chain amino acids leucine and isoleucine, ornithine, the acylcarnitines C3:0-, C16:0-, and C18:0-carnitine, and lysophosphatidylcholine (lyso-PC) C16:0 (area under the ROC curve, 0.77 [P = 0.00023] at baseline and 0.80 [P = 0.000019] at follow-up). Among the individual metabolites, predominantly higher levels of lyso-PC C16:0, both at baseline (P = 0.0039) and at follow-up (P = 0.001), were found in the insulin-sensitive compared with the insulin-resistant subjects. In the non-NAFL groups, no differences in lyso-PC C16:0 levels were found between the insulin-sensitive and insulin-resistant subjects, and these relationships were replicated in plasma from subjects with liver tissue samples.CONCLUSIONSFrom a plasma metabolomic pattern, particularly lyso-PCs are able to separate metabolically benign from malignant NAFL in humans and may highlight important pathways in the pathogenesis of fatty liver-induced insulin resistance.
Funding Organization6,9 ; 6,9 ; 6,9 ; 6,9
WOS IDWOS:000327252600049
Citation statistics
Cited Times:50[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Corresponding AuthorNorbert Stefan
Affiliation1.Univ Hosp Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany
2.Univ Tubingen, Inst Diabet Res & Metab Dis, Tubingen, Germany
3.Univ Tubingen, Ctr Bioinformat, Tubingen, Germany
4.Univ Tubingen, Med Proteome Ctr, Inst Ophthalm Res, Tubingen, Germany
5.Univ Tubingen, Inst Pathol, Tubingen, Germany
6.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China
7.Univ Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany
8.Univ Tubingen, Sect Expt Radiol, Tubingen, Germany
9.Helmholtz Zentrum, Inst Expt Genet, Munich, Germany
10.Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
11.Univ Tubingen, Stuttgart, Germany
12.CNR, Inst Clin Physiol, Pisa, Italy
Recommended Citation
GB/T 7714
Lehmann, Rainer,Franken, Holger,Dammeier, Sascha,et al. Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver[J]. DIABETES CARE,2013,36(8):2331-2338.
APA Lehmann, Rainer.,Franken, Holger.,Dammeier, Sascha.,Rosenbaum, Lars.,Kantartzis, Konstantinos.,...&Norbert Stefan.(2013).Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver.DIABETES CARE,36(8),2331-2338.
MLA Lehmann, Rainer,et al."Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver".DIABETES CARE 36.8(2013):2331-2338.
Files in This Item:
File Name/Size DocType Version Access License
201364j5EwKiLg.PDF(1148KB) 开放获取CC BY-NC-SAApplication Full Text
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Lehmann, Rainer]'s Articles
[Franken, Holger]'s Articles
[Dammeier, Sascha]'s Articles
Baidu academic
Similar articles in Baidu academic
[Lehmann, Rainer]'s Articles
[Franken, Holger]'s Articles
[Dammeier, Sascha]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Lehmann, Rainer]'s Articles
[Franken, Holger]'s Articles
[Dammeier, Sascha]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.